Literature DB >> 3332066

Studies on bacteriophage penetration in patients subjected to phage therapy.

B Weber-Dabrowska1, M Dabrowski, S Slopek.   

Abstract

Two healthy volunteers and 56 patients with suppurative bacterial infections were tested for penetration of oral administered bacteriophage to the blood circulation system and urinary tract. In the blood and urine samples collected from patients before phage therapy application, no presence of "wild phages" was confirmed. Examination performed on the 10th day of phage therapy revealed the presence of bacteriophages in 47 of 56 blood samples tested; positive result of examination was obtained in 9 cases of 26 urine samples.

Entities:  

Mesh:

Year:  1987        PMID: 3332066

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  23 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.

Authors:  Sanna Sillankorva; Dulce Oliveira; Alexandra Moura; Mariana Henriques; Alberta Faustino; Ana Nicolau; Joana Azeredo
Journal:  Curr Microbiol       Date:  2010-12-08       Impact factor: 2.188

4.  Immunogenicity studies of proteins forming the T4 phage head surface.

Authors:  Krystyna Dąbrowska; Paulina Miernikiewicz; Agnieszka Piotrowicz; Katarzyna Hodyra; Barbara Owczarek; Dorota Lecion; Zuzanna Kaźmierczak; Andrey Letarov; Andrzej Górski
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 5.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

6.  Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.

Authors:  Anne Bruttin; Harald Brüssow
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Bacteriophage K for reduction of Staphylococcus aureusbiofilm on central venous catheter material.

Authors:  Matthew P Lungren; Diana Christensen; Ravi Kankotia; Irene Falk; Ben E Paxton; Charles Y Kim
Journal:  Bacteriophage       Date:  2013-10-24

8.  Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.

Authors:  Sanjay Chhibber; Tarsem Kaur
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 9.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

Review 10.  A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.

Authors:  Victor Krylov; Olga Shaburova; Sergey Krylov; Elena Pleteneva
Journal:  Viruses       Date:  2012-12-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.